NCT06064097 2026-03-19A Study Using Nivolumab, in Combination With Chemotherapy Drugs to Treat Nasopharyngeal Carcinoma (NPC)National Cancer Institute (NCI)Phase 2 Recruiting50 enrolled
NCT06980038 2026-03-19Testing Whether Cemiplimab (REGN2810) Plus CDX-1140 Given Prior to Surgery Are Better Than Cemiplimab (REGN2810) Alone in Patients With Stage III-IV Head and Neck CancerNational Cancer Institute (NCI)Phase 2 Recruiting44 enrolled